Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Experimental & Molecular Medicine ; : e109-2014.
Article Dans Anglais | WPRIM | ID: wpr-103503

Résumé

Hepatic ischemia/reperfusion (I/R) injury leads to oxidative stress and acute inflammatory responses that cause liver damage and have a considerable impact on the postoperative outcome. Much research has been performed to develop possible protective techniques. We aimed to investigate the efficacy of SPA0355, a synthetic thiourea analog, in an animal model of hepatic I/R injury. Male C57BL/6 mice underwent normothermic partial liver ischemia for 45 min followed by varying periods of reperfusion. The animals were divided into three groups: sham operated, I/R and SPA0355 pretreated. Pretreatment with SPA0355 protected against hepatic I/R injury, as indicated by the decreased levels of serum aminotransferase and reduced parenchymal necrosis and apoptosis. Liver synthetic function was also restored by SPA0355 as reflected by the prolonged prothrombin time. To gain insight into the mechanism involved in this protection, we measured the activity of nuclear factor-kappaB (NF-kappaB), which revealed that SPA0355 suppressed the nuclear translocation and DNA binding of NF-kappaB subunits. Concomitantly, the expression of NF-kappaB target genes such as IL-1beta, IL-6, TNF-alpha and iNOS was significantly downregulated. Lastly, the liver antioxidant enzymes superoxide dismutase, catalase and glutathione were upregulated by SPA0355 treatment, which correlated with the reduction in serum malondialdehyde. Our results suggest that SPA0355 pretreatment prior to I/R injury could be an effective method to reduce liver damage.


Sujets)
Animaux , Mâle , Anti-inflammatoires/usage thérapeutique , Benzoxazines/usage thérapeutique , Foie/effets des médicaments et des substances chimiques , Souris de lignée C57BL , Facteur de transcription NF-kappa B/immunologie , Lésion d'ischémie-reperfusion/traitement médicamenteux , Transduction du signal/effets des médicaments et des substances chimiques , Thiourée/analogues et dérivés
2.
Experimental & Molecular Medicine ; : 313-319, 2008.
Article Dans Anglais | WPRIM | ID: wpr-205425

Résumé

Xanthohumol (XH), the principal prenylflavonoid of the hop plant (Humulus lupulus L.), dose-dependently inhibited isobutylmethylxanthine (IBMX)-induced melanogenesis in B16 melanoma cells, with little cytotoxicity at the effective concentrations. Decreased melanin content was accompanied by reduced tyrosinase enzyme activity, protein and mRNA expression. The levels of tyrosinase-related protein 1 and 2 mRNAs were decreased by XH. XH also inhibited alpha-melanocyte stimulating hormone- or forskolin-induced increases in melanogenesis, suggesting an action on the cAMP-dependent melanogenic pathway. XH downregulated the protein and mRNA expression of microphthalmia-associated transcription factor (MITF), a master transcriptional regulator of key melanogenic enzymes. These results suggest that XH might act as a hypo-pigmenting agent through the downregulation of MITF in the cAMP-dependent melanogenic pathway.


Sujets)
Animaux , Souris , Xanthine(isobutyl-3 methyl-1)/pharmacologie , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Régulation négative , Antagonisme des médicaments , Colforsine/pharmacologie , Humulus , Intramolecular oxidoreductases/antagonistes et inhibiteurs , Mélanines/antagonistes et inhibiteurs , Mélanocytes/effets des médicaments et des substances chimiques , Mélanome expérimental , Glycoprotéines membranaires/antagonistes et inhibiteurs , Facteur de transcription associé à la microphtalmie/antagonistes et inhibiteurs , Monophenol monooxygenase/antagonistes et inhibiteurs , Oxidoreductases/antagonistes et inhibiteurs , Propiophénones/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiques , Hormone mélanotrope alpha/métabolisme
3.
Korean Journal of Dermatology ; : 332-337, 2007.
Article Dans Coréen | WPRIM | ID: wpr-72448

Résumé

BACKGROUND: Numerous reports suggest the role of oxygen in melanogenesis. However, little has been reported on the effect of a hypoxic environment on cellular melanogenesis. OBJECTIVE: The effect of low oxygen tension on cellular melanogenesis was investigated in B16 murine melanoma cells. METHODS: Using cells cultured under an ambient (21% O2) or hypoxic (5% O2) condition, melanin content and tyrosinase activity were measured spectrophotometrically. The expression of tyrosinase, tyrosinase-related protein (TRP)- 1, and TRP-2 were analyzed by RT-PCR and Western blot. RESULTS: Culture of cells under hypoxic conditions caused significant inhibition of isobutylmethylxanthine (IBMX)- induced increase of melanin content. No cytotoxicity was observed during the hypoxic culture periods. Decreased melanin content occurred through the decrease of tyrosinase protein and activity (p<0.01). The mRNA levels of tyrosinase and TRP-2 were also decreased by hypoxia, while that of TRP-1 was unchanged. Similar inhibitions of melanin content and tyrosinase activity were observed in the cells stimulated with dibutyryl-cAMP. CONCLUSION: IBMX-induced melanogenesis in B16 cells was significantly inhibited under hypoxic culture conditions, suggesting the important role of oxygen tension in cellular melanogenesis.


Sujets)
Hypoxie , Technique de Western , Mélanines , Mélanome , Mélanome expérimental , Monophenol monooxygenase , Oxygène , ARN messager
SÉLECTION CITATIONS
Détails de la recherche